Clinical Trial Update: Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating tezepelumab for airway inflammation in adults with uncontrolled asthma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Bronchial Diseases | Phase 2 | Status: COMPLETED | Results posted: 2022-02-21